PUMA BIOTECHNOLOGY, INC. Quarterly Amortization of Intangible Assets in USD from Q3 2017 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
Summary
Puma Biotechnology, Inc. quarterly/annual Amortization of Intangible Assets history and growth rate from Q3 2017 to Q2 2024.
  • Puma Biotechnology, Inc. Amortization of Intangible Assets for the quarter ending June 30, 2024 was $2.4M, unchanged year-over-year.
  • Puma Biotechnology, Inc. Amortization of Intangible Assets for the twelve months ending June 30, 2024 was $9.7M, a 10.2% increase year-over-year.
  • Puma Biotechnology, Inc. annual Amortization of Intangible Assets for 2023 was $9.7M, a 21.3% increase from 2022.
  • Puma Biotechnology, Inc. annual Amortization of Intangible Assets for 2022 was $8M, unchanged from 2021.
  • Puma Biotechnology, Inc. annual Amortization of Intangible Assets for 2021 was $8M, a 27% increase from 2020.
Amortization of Intangible Assets, Trailing 12 Months (USD)
Amortization of Intangible Assets, Quarterly (USD)
Amortization of Intangible Assets, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $9.7M $2.4M $0 0% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-01
Q1 2024 $9.7M $2.4M $0 0% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $9.7M $2.5M +$500K +25% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 $9.2M $2.4M +$400K +20% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-02
Q2 2023 $8.8M $2.4M +$400K +20% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-01
Q1 2023 $8.4M $2.4M +$400K +20% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 $8M $2M $0 0% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 $8M $2M $0 0% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 $8M $2M $0 0% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 $8M $2M $0 0% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $8M $2M $0 0% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-29
Q3 2021 $8M $2M $0 0% Jul 1, 2021 Sep 30, 2021 10-Q 2021-11-04
Q2 2021 $8M $2M +$700K +53.8% Apr 1, 2021 Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $7.3M $2M +$1M +100% Jan 1, 2021 Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $6.3M $2M +$1.1M +122% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-02
Q3 2020 $5.2M $2M +$1M +100% Jul 1, 2020 Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $4.2M $1.3M +$300K +30% Apr 1, 2020 Jun 30, 2020 10-Q 2020-08-06
Q1 2020 $3.9M $1M $0 0% Jan 1, 2020 Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $3.9M $900K $0 0% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-03
Q3 2019 $3.9M $1M $0 0% Jul 1, 2019 Sep 30, 2019 10-Q 2019-11-07
Q2 2019 $3.9M $1M $0 0% Apr 1, 2019 Jun 30, 2019 10-Q 2019-08-09
Q1 2019 $3.9M $1M $0 0% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 $3.9M $900K Oct 1, 2018 Dec 31, 2018 10-K 2021-03-01
Q3 2018 $1M +$400K +66.7% Jul 1, 2018 Sep 30, 2018 10-Q 2018-11-05
Q2 2018 $1M Apr 1, 2018 Jun 30, 2018 10-Q 2018-08-09
Q1 2018 $1M Jan 1, 2018 Mar 31, 2018 10-Q 2018-05-10
Q3 2017 $600K Jul 1, 2017 Sep 30, 2017 10-Q 2017-11-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.